Does insurance coverage for a clotting drug change heart surgery recovery?
NCT ID NCT07457879
Summary
This study looks back at patient records to see if a change in insurance coverage for a medication called fibrinogen concentrate changed how patients were treated during complex heart surgery. Researchers will compare about 450 patients from before and after the coverage change to see if it led to fewer blood transfusions, shorter hospital stays, or better survival rates. The goal is to understand how payment policies affect real-world medical care and patient outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H.U.B - Hôpital Erasme
Brussels, 1070, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.